scholarly article | Q13442814 |
P2093 | author name string | T Kobayashi | |
H Honda | |||
T Wakabayashi | |||
J Yoshida | |||
M Shinkai | |||
M Yanase | |||
P2860 | cites work | Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells | Q36812848 |
Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain | Q41501229 | ||
Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant | Q42798198 | ||
Interstitial microwave antennas for thermal therapy | Q43736017 | ||
Experimental study on thermal damage to dog normal brain | Q48097685 | ||
Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. | Q54965829 | ||
Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. | Q54994628 | ||
Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. | Q55263240 | ||
Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling | Q69383993 | ||
Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia | Q70560424 | ||
Observations on the use of ferromagnetic implants for inducing hyperthermia | Q71355302 | ||
Development of intra-arterial hyperthermia using a dextran-magnetite complex | Q71679449 | ||
V delta 5+ T cells of BALB/c mice recognize the murine heat shock protein 60 target cell specificity | Q72674466 | ||
P433 | issue | 7 | |
P1104 | number of pages | 8 | |
P304 | page(s) | 775-782 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
P1476 | title | Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. | |
P478 | volume | 89 |
Q34245109 | Acute and long-term effects of hyperthermia in B16-F10 melanoma cells |
Q38260733 | Antitumor immunity by magnetic nanoparticle-mediated hyperthermia |
Q37889662 | Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment |
Q39829640 | Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy |
Q36245290 | Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression |
Q52917224 | Clinical applications of magnetic nanoparticles for hyperthermia. |
Q90145195 | Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients |
Q40356997 | Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core |
Q47364775 | Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles |
Q90608679 | Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy |
Q36964967 | Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation |
Q35017212 | Effect of distilled water on rapid inactivation of tumour cells attached to surgery instruments |
Q42091216 | Effect of interleukin-2 treatment combined with magnetic fluid hyperthermia on Lewis lung cancer-bearing mice |
Q34357688 | Effect of magnetic fluid hyperthermia on lung cancer nodules in a murine model |
Q48582266 | Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study |
Q37794066 | Engineering nanocomposite materials for cancer therapy |
Q89475558 | Enhancing cancer immunotherapy with nanomedicine |
Q42610903 | Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia. |
Q39807525 | Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer |
Q37383547 | Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy |
Q45871523 | Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles |
Q42176403 | Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles |
Q38161993 | In vivo applications of magnetic nanoparticle hyperthermia |
Q51504570 | Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. |
Q36918053 | Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications. |
Q33993679 | Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors |
Q26823968 | Local tumour hyperthermia as immunotherapy for metastatic cancer |
Q47663260 | Magnetic Nanotransducers in Biomedicine. |
Q47721799 | Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy, and application in humans |
Q36345256 | Magnetic nanoparticles and nanocomposites for remote controlled therapies |
Q38694418 | Magnetohyperthermia for treatment of gliomas: experimental and clinical studies |
Q90193231 | Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy |
Q33405614 | Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine |
Q39686211 | Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release |
Q90282942 | Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy |
Q47158949 | Nanoscale thermal phenomena in the vicinity of magnetic nanoparticles in alternating magnetic fields |
Q28246583 | Nanotechnology: intelligent design to treat complex disease |
Q37331799 | Optimizing magnetic nanoparticle design for nanothermotherapy |
Q91690264 | PMMA-Fe3O4 for internal mechanical support and magnetic thermal ablation of bone tumors |
Q47378913 | Recent advances in nanomedicine and survivin targeting in brain cancers |
Q38102018 | Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research |
Q38352950 | Screening of stress enhancer based on analysis of gene expression profiles: enhancement of hyperthermia-induced tumor necrosis by an MMP-3 inhibitor |
Q55035554 | Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. |
Q89551657 | Therapeutic Efficiency of Multiple Applications of Magnetic Hyperthermia Technique in Glioblastoma Using Aminosilane Coated Iron Oxide Nanoparticles: In Vitro and In Vivo Study |
Q50069637 | Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans |
Q39440624 | Tumor local chemohyperthermia using docetaxel-embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia |
Q34208635 | Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma |
Q55432713 | [Effects of magnetic fluid hyperthermia induced by an alternative magnetic field on human carcinoma A549 cell in vitro]. |
Search more.